BMT Tandem "Scientific" Meeting
Ballroom I-J (Salt Palace Convention Center)
Chairs:
Frederic Baron, MD, PhD
and
Marcos de Lima, MD
Summary:
Abstracts: #2832, 2613, 2217, 2514, 2546, 2835
CMV Replication After Allogeneic Hematopoietic Cell Transplantation and Relapse Risk: Evidence for Early Protection Against Relapse in Acute Leukemia and Lymphoma
Margaret L. Green, MD, MPH, Fred Hutchinson Cancer Research Center;
Roland B. Walter, MD, Fred Hutchinson Cancer Research Center;
Hu Xie, Fred Hutchinson Cancer Research Center;
Wendy Leisenring, Fred Hutchinson Cancer Research Center;
Marco Mielcarek, MD, Fred Hutchinson Cancer Research Center;
Brenda M. Sandmaier, MD, Fred Hutchinson Cancer Research Center;
Stanley Riddell, MD, Fred Hutchinson Cancer Research Center;
Michael J. Boeckh, MD, Fred Hutchinson Cancer Research Center
Association Between AGT SNPs, Plasma AGT Levels, and Risk for IPS After Allogeneic HCT
Makoto Onizuka, MD, PhD, Tokai University School of Medicine;
Yao Li, Fred Hutchinson Cancer Research Center;
Wenhong Fan, Fred Hutchinson Cancer Research Center;
Cindy Zhang, Fred Hutchinson Cancer Research Center;
Hongwei Wang, Fred Hutchinson Cancer Research Center;
Lue Ping Zhao, Fred Hutchinson Cancer Research Center;
David K. Madtes, MD, University of Washington;
Paul J Martin, MD, Fred Hutchinson Cancer Research Center;
Barry Storer, PhD, Fred Hutchinson Cancer Research Center;
John A. Hansen, MD, Fred Hutchinson Cancer Research Center;
Jason Chien, MD, M.Sc., Fred Hutchinson Cancer Research Center
Human Rhinovirus RNA Detection in the Lower Respiratory Tract of Hematopoietic Cell Transplant Recipients: Association with Mortality
Sachiko Seo, Fred Hutchinson Cancer Research Center;
Emily Martin, Washington State University;
Hu Xie, Fred Hutchinson Cancer Research Center;
Jane M Kuypers, University of Washington;
Angela P Campbell, Seattle Children's Hospital/Fred Hutchinson Cancer Research Ctr/Univ of Washington;
Su-Mi Choi, The Catholic University of Korea;
Alpana Waghmare, University of Washington;
Wendy Leisenring, Fred Hutchinson Cancer Research Center;
Keith Jerome, University of Washington;
Janet A Englund, University of Washington School of Medicine;
Michael J. Boeckh, MD, Fred Hutchinson Cancer Research Center
One-Year Safety and Immunogenicity of Two Formulations of an Adjuvanted Varicella-Zoster VIRUS (VZV) Subunit Candidate Vaccine in Adult Autologous Hematopoietic CELL Transplant (HCT) Recipients
Edward A. Stadtmauer, MD, University of Pennsylvania;
Keith Sullivan, M.D., Duke University Medical Center;
Francisco Marty, MD, Dana-Farber Cancer Institute;
Sanjeet S Dadwal, MD, City of Hope;
Genovefa A Papanicoleau, MD, Memorial Sloan-Kettering Cancer Center;
Thomas C. Shea, MD, University of North Carolina at Chapel Hill;
Sherif B Mossad, MD, Cleveland Clinic Foundation;
Charalambos Andreadis, MD, MSCE, UCSF;
Jo-Anne Young, MD, FACP, University of Minnesota;
Francis Buadi, MD, UT Blood and Marrow Transplant Center;
Mindy G Schuster, MD, Abramson Cancer Center, University of Pennsylvania;
Mohamed Idrissi, GlaxoSmithKline Vaccines;
Thomas Heineman, GlaxoSmithKline Vaccines;
Elchonon M Berkowitz, GlaxoSmithKline Vaccines
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (etanercept) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Gregory Yanik, M.D., University of Michigan;
Vincent T. Ho, MD, Dana-Farber Cancer Institute;
Mary Horowitz, MD, Medical College of Wisconsin;
Daniel J. Weisdorf, MD, University of Minnesota;
Brent R. Logan, PhD, Medical College of Wisconsin;
Juan Wu, The EMMES Corporation;
Robert J. Soiffer, MD, Dana-Farber Cancer Institute;
John R Wingard, MD, University of Florida;
John E Levine, M.D., M.S., University of Michigan;
James L.M. Ferrara, M.D., D.Sc., University of Michigan;
Sergio A. Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Eric White, MD, University of Michigan;
Shelly L Carter, ScD, The EMMES Corporation;
Nancy DiFronzo, PhD, NIH/NHLBI;
Kenneth R. Cooke, MD, University Hospitals Case Western Reserve
Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)
Richard Nash, MD, Fred Hutchinson Cancer Research Center;
George J. Hutton, MD, Baylor College;
Michael Racke, MD, Ohio State University;
Uday Popat, MD, UT MD Anderson Cancer Center;
Steven M Devine, MD, The Ohio State University;
George Georges, MD, Fred Hutchinson Cancer Research Center;
Linda Griffith, MD, PhD, Dait, Niaid, Nih;
Paolo A. Muraro, MD, PhD, Imperial College, Hammersmith Hospital;
Harry Openshaw, MD, City of Hope;
Peter Sayre, MD, University of California San Francisco;
Olaf Stuve, University of Texas Southwestern;
Douglas Arnold, MD, McGill University;
Meagan Spychala, DrPH, Rho Federal Systems Division, Inc;
Noha Lim, PhD, Immune Tolerance Network;
Sachin Malhotra, PhD, Immune Tolerance Network;
Deborah Phippard, PhD, Immune Tolerance Network;
Annette Wundes, MD, University of Washington;
George H Kraft, MD, University of Washington;
James D Bowen, MD, University of Washington
![[Visit Client Website]](images/banner.gif)